Co-Diagnostics Inc (CODX)
$17.47
0.72 (3.96%)
CODX Stock Quote Delayed 30 Minutes
Previous Close
$18.19
Market Cap
215.34M
PE Ratio
-28.47
EPS
-0.613619
Volume (Avg. Vol.)
1.90M
Day's Range
17.45 - 18.70
52-Week Range
0.85 - 29.72
Dividend & Yield
N/A (N/A)
CODX Stock Predictions, Articles, and Co-Diagnostics Inc News
Co-Diagnostics Stock: Trading the Russell 2000 Index Catalyst
Co-Diagnostics will be on the move over the next week. Don't confuse a technical trade for a strong long-term investment case in CODX stock.
Co-Diagnostics Gets Sued, Investors Shrug
Monday's lawsuit hasn't impacted the chart of Co-Diagnostics one bit. Here are the price levels in CODX stock that I'd trade around right now.
Co-Diagnostics Stock Is a Fun Day Trade but It Is No Investment
CODX stock will start to tumble back to earth as more competitors enter the testing space, and the impact of Covid-19 subsides.
Don’t Cancel Your Visit With Co-Diagnostics Stock Just Yet
CODX stock took a hit as economic indicators suggested a sooner-than-expected recovery. But don’t completely ignore shares just yet.
Co-Diagnostics Stock Will Meet High Analyst Expectations
The price target for CODX stock has been raised, but the testing-kit leader should easily clear the bar. More upside ahead.
It May Be Time to Take Profits in Co-Diagnostics Stock
The rush to develop a COVID-19 diagnostic test has pushed CODX stock to new highs. But investors may need more scientific evidence to stay in the shares long-term.
Co-Diagnostics Could Be a Prudent Coronavirus Play
CODX stock could continue delivering upside if its novel coronavirus test kit proves accurate and vaccines take awhile to come to market.
Make This Biotech Play if You Like Co-Diagnostics’ Chances
From an investment standpoint, I’m always thinking about my options. I don’t necessarily have to invest in CODX stock because there are other potential options available, ones probably safer in the grand scheme of things.
Co-Diagnostics Stock Is Up 1,800%, So Bet on the Next Burst
The fear of missing out is a real stock price driver. Add to it the fear of the virus and you get unlimited upside potential for CODX stock.
Co-Diagnostics Stock Will Be Weighed Down by Multiple Issues
There's evidence that Co-Diagnostics' test is not as accurate as many of its competitors' offerings. That makes CODX stock quite risky.
Co-Diagnostics Could Soar With Its Coronavirus Test
Co-Diagnostics may be worth much more than today's price. CODX stock could be worth two or three times more, under certain estimates.
Co-Diagnostics’ Test Kits Still Make CODX Stock a Great Buy
Co-Diagnostics benefits from the quantity and quality of its test kits. This means CODX stock should long be one of investors' favorites.
Co-Diagnostics Stock Positioned for Continued Growth in 2020
Co-Diagnostics has seen its business explode because of the coronavirus pandemic and CODX stock is up over 1800% so far in 2020.
Stop the Insanity with Co-Diagnostics Stock Already
The last thing you need in your portfolio is a drastically volatile asset. Avoid CODX stock in both short- and long-term trades.
Dump Co-Diagnostics Stock Before It’s Too Late
After a dreadful earnings report and conference call, the good times are over for Co-Diagnostics. CODX stock will continue to sink in coming days.
Co-Diagnostics Stock Is a Buy Ahead of and After Earnings
Co-Diagnostics stock has emerged as a big winner from Covid-19. Testing for novel viruses may make it a long-term winner in the new normal.
Co-Diagnostics Is a Smart Way to Play Coronavirus Testing
Co-Diagnostics says its coronavirus tests are 100% accurate in tests in three countries, making CODX stock a smart play.
Navellier Ratings
Powered by Portfolio GraderTotal Grade
A
